Regulation of phagocyte function by Rac2

Rac2 对吞噬细胞功能的调节

基本信息

项目摘要

The Rho family GTPase Rac plays a key role in regulating a variety of phagocyte functions, including NADPH oxidase-catalyzed superoxide generation, Fcgamma receptor-mediated phagocytosis, and cytoskeletal changes during membrane ruffling and cell movement. To examine the role of the hematopoietic specific Rac2 GTPase, which is approximately 90% identical to the more widely expressed Rac1 and Rac3 isoforms, mice with a targeted disruption of the Rac2 gene were generated. NADPH oxidase activation in Rac2-deficient neutrophils )which still express Rac1) was substantially reduced in response to fMLP, IgG- opsonized particles, and phorbol ester, but normal in response to complement-coated zymosan. Other neutrophil defects observed in initial studies include impaired actin polymerization, chemotaxis, and poor L-selectin-dependent adhesion. In addition, mice exhibited decreased exudate formulation in vivo and an increased susceptibility to invasive Aspergillosis. An important role for Rac in neutrophil function has been further established by the identification of a dominant-negative mutant of Rac2 in an infant who presented with recurrent pyogenic infections and functional neutrophil defects similar to those found in Rc2-/-. These data suggest that Rac2 regulates multiple cellular responses in phagocytes downstream of specific receptor-activated pathways, and has non-overlapping functions with Rac1 and Rac3 in the host infection and inflammation. Project 3 will focus on testing this hypothesis, particular as it relates to activation of the NADPH oxidase, and explore underlying biochemical mechanisms. There are four Specific Aims, which will take advantage of the Rac2-/- mouse. These propose to (1) further define defects in Rac2-/- phagocytes to examine macrophage superoxide production, phagocytosis, and chemoattractant-induced movement; (2) examine whether functional defects in Rac2-/- phagocytes, and chemoattractant-induced movement; (2) examine whether functional defects in Rac2-/- phagocytes reflect selective activation, localization, or usage of Rac2, and if specific Rac2 effector sequences are required; (3) investigate upstream and downstream signaling events involved in Rac-dependent assembly of the NADPH oxidase complex and (4) determine the impact of Rac2 deficiency on host defense and inflammation. This work will provide further insight into how Rho-GTPases regulate phagocytic leukocyte functions and the biochemical mechanisms that mediate specific agonist-induced cellular responses. These studies may also result in new approaches to modulating phagocyte function in inflammation and host defense.
Rho家族GTdR ac在调节多种吞噬细胞功能中起关键作用,包括NADPH氧化酶催化的超氧化物生成、Fc γ受体介导的吞噬作用以及膜皱褶和细胞运动期间的细胞骨架变化。为了检查造血特异性Rac 2 GTdR的作用,其与更广泛表达的Rac 1和Rac 3同种型约90%相同,产生了具有Rac 2基因靶向破坏的小鼠。在仍然表达Rac 1的Rac 2缺陷型嗜中性粒细胞中,NADPH氧化酶的活化在对fMLP、IgG调理颗粒和佛波酯的应答中显著降低,但在对补体包被的酵母聚糖的应答中正常。在最初的研究中观察到的其他中性粒细胞缺陷包括受损的肌动蛋白聚合、趋化性和较差的L-选择素依赖性粘附。此外,小鼠体内渗出液减少,对侵袭性铜绿假单胞菌病的易感性增加。Rac在中性粒细胞功能中的重要作用已通过鉴定Rac 2的显性阴性突变体而进一步确定,该突变体表现为复发性化脓性感染和与Rc 2-/-中发现的类似的功能性中性粒细胞缺陷。这些数据表明,Rac 2调节吞噬细胞下游的特异性受体激活途径的多种细胞反应,并在宿主感染和炎症中与Rac 1和Rac 3具有非重叠的功能。项目3将重点测试这一假设,特别是因为它涉及到NADPH氧化酶的激活,并探索潜在的生化机制。有四个特定目标,这将利用Rac 2-/-鼠标。这些建议(1)进一步定义Rac 2-/-吞噬细胞中的缺陷,以检查巨噬细胞超氧化物的产生、吞噬作用和化学引诱剂诱导的运动;(2)检查Rac 2-/-吞噬细胞中是否存在功能缺陷,以及化学引诱剂诱导的运动;(2)检查Rac 2-/-吞噬细胞中的功能缺陷是否反映Rac 2的选择性激活、定位或使用,以及是否需要特异性Rac 2效应子序列;(3)研究参与NADPH氧化酶复合物的Rac依赖性组装的上游和下游信号传导事件和(4)确定Rac 2缺陷对宿主防御和炎症的影响。这项工作将提供进一步了解Rho-GTPases如何调节吞噬白细胞功能和介导特定激动剂诱导的细胞反应的生化机制。这些研究也可能导致在炎症和宿主防御中调节吞噬细胞功能的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary C Dinauer其他文献

Mary C Dinauer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary C Dinauer', 18)}}的其他基金

SELECTIVE DELETION OF NEUTROPHIL NADPH OXIDASE AND INNATE RESPONSES TO ASPERGILLUS FUMIGATUS
中性粒细胞 NADPH 氧化酶的选择性缺失和对烟曲霉的先天反应
  • 批准号:
    9368526
  • 财政年份:
    2017
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    7458723
  • 财政年份:
    2007
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    7440956
  • 财政年份:
    2006
  • 资助金额:
    $ 21.74万
  • 项目类别:
2005 Phagocytes Gordon Conference
2005年吞噬细胞戈登会议
  • 批准号:
    7001142
  • 财政年份:
    2005
  • 资助金额:
    $ 21.74万
  • 项目类别:
Administrative
行政的
  • 批准号:
    7414661
  • 财政年份:
    2005
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    7089588
  • 财政年份:
    2005
  • 资助金额:
    $ 21.74万
  • 项目类别:
Core C- Administrative Core
核心 C- 行政核心
  • 批准号:
    6987703
  • 财政年份:
    2004
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    6879596
  • 财政年份:
    2004
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    6105676
  • 财政年份:
    1998
  • 资助金额:
    $ 21.74万
  • 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
  • 批准号:
    6110406
  • 财政年份:
    1998
  • 资助金额:
    $ 21.74万
  • 项目类别:

相似海外基金

Dynamic Imaging in Viral Encephalitis Defines Unique Roles for Chemoattractants.
病毒性脑炎的动态成像定义了化学引诱剂的独特作用。
  • 批准号:
    MR/T028750/1
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Research Grant
Chemoattractants for sperm in Bombix mori
家蚕精子的化学引诱剂
  • 批准号:
    20K15538
  • 财政年份:
    2020
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clarification of eosinophilic chemoattractants in chronic subdural hematoma outer membrane
慢性硬膜下血肿外膜中嗜酸性趋化剂的澄清
  • 批准号:
    17K10853
  • 财政年份:
    2017
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Soluble Motogens and Chemoattractants from Damaged Muscle
受损肌肉中的可溶性促动力剂和化学引诱剂
  • 批准号:
    8383029
  • 财政年份:
    2012
  • 资助金额:
    $ 21.74万
  • 项目类别:
Soluble Motogens and Chemoattractants from Damaged Muscle
受损肌肉中的可溶性促动力剂和化学引诱剂
  • 批准号:
    8500217
  • 财政年份:
    2012
  • 资助金额:
    $ 21.74万
  • 项目类别:
Chemokines and chemoattractants: a hierarchy of signals to allow neutrophil chemotaxis to sites of infection
趋化因子和趋化剂:允许中性粒细胞趋化至感染部位的信号层次
  • 批准号:
    190259
  • 财政年份:
    2009
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Operating Grants
Role of Chemoattractants in Hepatic Stellate Cell Recruitment and Fibrogenesis in Paediatric Cholestatic Liver Disease.
化学引诱剂在小儿胆汁淤积性肝病肝星细胞募集和纤维形成中的作用。
  • 批准号:
    nhmrc : 496602
  • 财政年份:
    2008
  • 资助金额:
    $ 21.74万
  • 项目类别:
    NHMRC Project Grants
Identification of Chemoattractants in Neural Crest Migration (pilot)
神经嵴迁移中化学引诱剂的鉴定(试点)
  • 批准号:
    7131852
  • 财政年份:
    2006
  • 资助金额:
    $ 21.74万
  • 项目类别:
SYNTHESIS OF LIPID BASED CHEMOATTRACTANTS
基于脂质的化学引诱剂的合成
  • 批准号:
    7181490
  • 财政年份:
    2005
  • 资助金额:
    $ 21.74万
  • 项目类别:
Molecular biological analysis of mechanisms for human embryo implantation and placentation-from the perspectrives of repulsive force, chemoattractants and membrane-bound peptidases
人胚胎着床和胎盘形成机制的分子生物学分析——从排斥力、趋化剂和膜结合肽酶的角度
  • 批准号:
    16390474
  • 财政年份:
    2004
  • 资助金额:
    $ 21.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了